Questions Remain For Samsung Bioepis Post-Biogen

Management Changes, Strategic Focus And Structural Aspects Yet To Be Decided

 
• By David Wallace
  
Question mark maze labyrinth
The future path for Samsung Bioepis is not yet fully decided • Source: Cagkan Sayin / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products